{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:21:05Z","timestamp":1778170865354,"version":"3.51.4"},"reference-count":21,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/mco.2016.1015","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T03:18:04Z","timestamp":1473736684000},"page":"641-646","source":"Crossref","is-referenced-by-count":49,"title":["Muscle wasting associated with the long-term use of mTOR inhibitors"],"prefix":"10.3892","volume":"5","author":[{"given":"Bishal","family":"Gyawali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Shimokata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Sassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momokazu","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"key20180107150225_b1-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"key20180107150225_b2-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107150225_b3-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bjs.7823","article-title":"Body composition and outcome in patients undergoing resection of colorectal liver metastases","volume":"99","author":"van Vledder","year":"2012","journal-title":"Br J Surg"},{"key":"key20180107150225_b4-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107150225_b5-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jamaoncol.2015.6339","article-title":"Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma","volume":"2","author":"Grossberg","year":"2016","journal-title":"JAMA Oncol"},{"key":"key20180107150225_b6-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107150225_b7-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"e37563","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"key":"key20180107150225_b8-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"key":"key20180107150225_b9-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1210\/jc.2013-1115","article-title":"Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study","volume":"98","author":"Massicotte","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107150225_b10-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180107150225_b11-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat Cell Biol"},{"key":"key20180107150225_b12-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1091\/mbc.01-12-0584","article-title":"Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake","volume":"13","author":"Edinger","year":"2002","journal-title":"Mol Biol Cell"},{"key":"key20180107150225_b13-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: Results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107150225_b14-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: Selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Prado","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107150225_b15-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20180107150225_b16-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"key20180107150225_b17-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"key20180107150225_b18-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"key20180107150225_b19-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13539-013-0113-y","article-title":"A pilot study of temsirolimus and body composition","volume":"4","author":"Veasey-Rodrigues","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20180107150225_b20-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1139\/h2012-009","article-title":"mTORC1 and the regulation of skeletal muscle anabolism and mass","volume":"37","author":"Adegoke","year":"2012","journal-title":"Appl Physiol Nutr Metab"},{"key":"key20180107150225_b21-mco-0-0-1015","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.1015\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T10:02:35Z","timestamp":1515319355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.1015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,9,13]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/mco.2016.1015"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.1015","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]}}}